- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2443EUR$2,789USD£2,120GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2443EUR$2,789USD£2,120GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2443EUR$2,789USD£2,120GBP
- Report
- June 2025
- 150 Pages
Global
From €2364EUR$2,699USD£2,052GBP
- Report
- June 2025
- 150 Pages
Global
From €2364EUR$2,699USD£2,052GBP
- Report
- May 2025
- 300 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- March 2025
- 145 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1095EUR$1,250USD£950GBP
- Report
- November 2025
- 145 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- February 2025
- 221 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2443EUR$2,789USD£2,120GBP
- Report
- June 2025
- 400 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- January 2026
- 128 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- June 2025
- 138 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- August 2025
- 260 Pages
Global
From €4375EUR$4,995USD£3,797GBP
- Report
- July 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- September 2025
- 142 Pages
Global
From €3500EUR$4,281USD£3,144GBP
- Report
- May 2025
- 90 Pages
Global
From €3500EUR$4,281USD£3,144GBP
- Report
- April 2025
- 90 Pages
Global
From €3500EUR$4,281USD£3,144GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more